Summary of patients and transplant characteristics
| . | Value . |
|---|---|
| Sex, n | |
| Male | 54 |
| Female | 52 |
| Ratio | 1.04 |
| PEG-ADA treatment, n | |
| Yes (> 3 mo) | 13 |
| No | 93 |
| Type of HCT, n | |
| MSD | 42 |
| MFD | 12 |
| MUD | 15 |
| MMUD | 7 |
| HAPLO | 30 |
| Intensity of conditioning, n | |
| None | 49 |
| RIC | 12 |
| MAC | 45 |
| Source of stem cell, n | |
| BM | 88 |
| PBSC | 9 |
| UCB | 9 |
| . | Value . |
|---|---|
| Sex, n | |
| Male | 54 |
| Female | 52 |
| Ratio | 1.04 |
| PEG-ADA treatment, n | |
| Yes (> 3 mo) | 13 |
| No | 93 |
| Type of HCT, n | |
| MSD | 42 |
| MFD | 12 |
| MUD | 15 |
| MMUD | 7 |
| HAPLO | 30 |
| Intensity of conditioning, n | |
| None | 49 |
| RIC | 12 |
| MAC | 45 |
| Source of stem cell, n | |
| BM | 88 |
| PBSC | 9 |
| UCB | 9 |
PEG-ADA indicates polyethylene glycol–adenosine deaminase; HCT, hematopoietic cell transplantation; MSD, matched sibling donor; MFD, matched family donor; MUD, matched unrelated donor; MMUD, mismatched unrelated donor; HAPLO, haploidential; RIC, reduced intensity conditioning; MAC, myeloablative intensity conditioning; BM, bone marrow; PBSC, peripheral blood stem cells; and UCB, umbilical cord blood.